Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenesis Inhibition in Oncology”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Testing effectiveness (Phase 2)Study completedNCT01321437
What this trial is testing

Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma

Who this might be right for
MelanomaMalignant MelanomaStage IIIA Melanoma+2 more
University of California, Irvine 11
Not applicableUnknownNCT01656824
What this trial is testing

Tissue Study of Bv8/PK-2 Inhibition in Human Cancer

Who this might be right for
Cancer
Rambam Health Care Campus 20
Testing effectiveness (Phase 2)Study completedNCT00602199
What this trial is testing

ABT-510 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 42
Testing effectiveness (Phase 2)Study completedNCT00995007
What this trial is testing

Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

Who this might be right for
Glioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 112
Early research (Phase 1)Study completedNCT00033215
What this trial is testing

S-3304 in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Shionogi 32
Early research (Phase 1)Study completedNCT01120288
What this trial is testing

A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases

Who this might be right for
NeoplasmsLiver Metastases
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07134218
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Changhai Hospital 180
Early research (Phase 1)Study completedNCT01688960
What this trial is testing

Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumors
Regeneron Pharmaceuticals 48
Early research (Phase 1)Study completedNCT00006155
What this trial is testing

SU5416 and Carboplatin to Treat Ovarian Cancer

Who this might be right for
Fallopian Tube NeoplasmOvarian CancerPeritoneal Neoplasm
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT00321581
What this trial is testing

AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia

Who this might be right for
Refractory or Recurrent Solid TumorsAcute Myelogenous Leukemia
National Cancer Institute (NCI) 18
Not applicableEnded earlyNCT01336231
What this trial is testing

Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Cancer
Centre Francois Baclesse 82
Testing effectiveness (Phase 2)Looking for participantsNCT06878625
What this trial is testing

A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer

Who this might be right for
Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 138
Testing effectiveness (Phase 2)Study completedNCT00667394
What this trial is testing

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 42
Not applicableUnknownNCT04137588
What this trial is testing

Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Advanced Non-squamous Non-small Cell Lung Cancer
Peking University Cancer Hospital & Institute 126
Testing effectiveness (Phase 2)Study completedNCT01006369
What this trial is testing

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Rutgers, The State University of New Jersey 38
Testing effectiveness (Phase 2)Study completedNCT06562673
What this trial is testing

Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma

Who this might be right for
OsteosarcomaBone Cancer
Shanghai 6th People's Hospital 10
Early research (Phase 1)Study completedNCT00322400
What this trial is testing

Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer

Who this might be right for
Locally Recurrent and Metastatic Breast Cancer
Amgen 46
Testing effectiveness (Phase 2)Study completedNCT00327171
What this trial is testing

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Who this might be right for
NeoplasmsCancer of the Ovary
Sanofi 218
Not applicableUnknownNCT04731909
What this trial is testing

Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageLung CancerSmall Cell Lung Cancer
Third Military Medical University 80
Large-scale testing (Phase 3)Study completedNCT03042611
What this trial is testing

Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Elevar Therapeutics 460
Load More Results